CXCL12 enhanced the migration of PCa cells, and inhibition of CXCR4 reversed the effects, and PCa patients with bone metastasis exhibited a higher positive rate of CXCR4 protein than bone metastasis negative patients (13). The gene discussed is CXCL12; the disease is posterior cortical atrophy.